avian-influenza

Looking beyond jabs, sprays or tablets, scientists are thinking outside the box for delivering antiviral medication to prevent the spread of highly transmissible bugs. Their secret weapon? Chewing gum – but one made from a rather fascinating bean.

Human protection against bird flu may be easier than previously thought, thanks to new findings about the genetic makeup of the virus and one particular immune cell that all of us have. It also paves the way for fast-tracking the first H5N1 vaccine.

In what may not come as much of a shock, the Doomsday Clock has inched closer to midnight and is now just 89 seconds from 12. It's the closest the hands have ever been to the symbolic 'end of times' number on the clock face in its 80 years.

The US has recorded its first death due to avian influenza. The man had been infected by a H5N1 variant with a genetic mutation, helping it target upper respiratory tract receptors – one also seen in the Canadian teen who fell critically ill last year.

Scientists are again on high alert, as whole genome sequencing of the H5N1 virus has revealed that it is capable of multidirectional infections across species. While human risk is low, it's a step forward for the pathogen in this biological arm's race.

It was only a matter of time, but highly pathogenic avian influence (HPAI) has officially found its way to Antarctica, after dead migratory brown skuas on Bird Island returned positive test results. This leaves just Oceania free of the deadly virus.